Serum STIP1 levels were not shown to significantly differ among patients with 4 clinical stages of ovarian cancer [9], but in this study tumor STIP1 histoscores were significantly higher in stages III–IV (n = 147) than stages I–II (n = 183) (Table 1). The gene discussed is STIP1; the disease is ovarian carcinoma.